← BioTransfer GEO Dataset Finder
GEO series

LNCAP/AR and a LnCAP/AR subline (LREX') with acquired resistance to 2nd generation antiandrogens

GSE51873 Homo sapiens Expression profiling by array 50 samples Submitted 2013/12/27 Platform GPL10558
Summary
The treatment of advanced prostate cancer has been transformed by novel antiandrogen therapies such as enzalutamide. Using the LnCaP/AR xenograft model, we identified induction of glucocorticoid receptor (GR) expression as a common feature of drug resistant tumors. From a resistant xenograft tumor, we derived a GR expressing resistant subline called LREX' which maintains the resistant phenotype. mRNA expression was used to characterize resistant tissues.
This dataset
Download

Direct links to NCBI, no account and no request form: the whole study as GSE51873_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 50 samples.

Also filed as BioProject PRJNA225675. Searching any of these in the dataset finder brings you back here.

Samples in this study

The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.

+ 50 more — browse all 50 samples with per-sample file links →

Similar datasets

Search all human microarray datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.